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Introduction {#sec1}
============

Adult neural stem cells (NSCs) are major candidates for regenerative therapies in demyelinating diseases. Myelin, provided by oligodendrocytes (OLs), is essential for the proper function of neurons in the central nervous system (CNS). Myelin loss occurs in many demyelinating diseases, such as multiple sclerosis (MS) and causes a variety of neurological disabilities in adults ([@bib19], [@bib34]). In demyelinating disease lesions OLs are lost and to promote functional recovery, lesions must be supplied with endogenous or transplanted myelinating cells ([@bib9], [@bib15], [@bib28]). Oligodendrocyte progenitor cells (OPCs) marked by NG2, a chondroitin sulfate proteoglycan, and PDGFRα (platelet-derived growth factor receptor α) are recruited to demyelinated lesions ([@bib14], [@bib44], [@bib45], [@bib52]). Olig2, a basic-helix-loop-helix transcription factor, is strongly upregulated in OPCs under pathological conditions and demyelination in the adult CNS ([@bib12], [@bib22], [@bib54]).

NSCs have been found in two main neurogenic regions of the brain ([@bib20]); the subgranular zone (SGZ) of the dentate gyrus (DG) in the hippocampus ([@bib2]) and the subventricular zone (SVZ) of the lateral ventricles (LVs) ([@bib24], [@bib35]). Neurogenesis may also occur in other areas of the adult brain---albeit at lower levels ([@bib50], [@bib56]). Recently, a novel site of NSCs was reported in the circumventricular organs (CVO) ([@bib6]). To date, studies focused on neurogenic niches directed mainly to neurogenesis with less attention to characterizing oligodendrogenic niches.

Studies of oligodendrogenesis in white matter regions of adult rodent CNS, revealed spontaneous NG2 cell division and new OLs formation ([@bib13], [@bib17], [@bib27], [@bib32], [@bib50]).

In contrast to multiple studies reporting spontaneous neurogenesis in various CNS disorders ([@bib55]) as well as in the murine model of MS, experimental autoimmune encephalomyelitis (EAE) ([@bib1]), spontaneous oligodendrogenesis was barely reported ([@bib40], [@bib42]).

The generation of new OLs in the SVZ was investigated extensively ([@bib10], [@bib29], [@bib51], [@bib63]), however, their ability to participate in myelin repair has remained uncertain. Nevertheless, it is of great importance to characterize niches of OPCs for their regulation in pathological conditions or re-population *in vitro* for further therapy. In addition, a number of molecules/molecular pathways were reported to regulate neurogenesis; however, the mechanism that preferentially directs oligodendrogenesis versus neurogenesis and lineage commitment is not yet clear.

Here, we looked into brain sites in naive mice that are highly enriched with bromodeoxyuridine (BrdU)^+^ newly proliferating cells. Of these, the median eminence (ME) was attractive for its exclusive oligodendrogenic fate. Identifying the ME as a site that preferentially hosts NG2 cells, we studied *in vitro* the self-renewal potential of ME-NSCs and the preferential differentiation to OLs compared with SVZ-NSCs. Indeed, we characterized the oligodendrogenic fate of ME-resident BrdU^+^ cells in naive and EAE mice. More practically, we studied their ability to differentiate toward mature MBP-producing OLs in *Shiverer* (*Shi*) mice, a model for demyelination. Comprehensively, we studied *in vitro* a potential role for thrombospondin 1 (TSP1) in regulating the oligodendrogenic versus neurogenic fate and compared the expression of TSP1 in SVZ and ME of naive with that of EAE mice.

We show that the ME of naive mice is enriched with BrdU^+^ NG2^+^ cells and that their number is increased in EAE mice. *In vitro*, ME-NSCs generate neurospheres (NSs) that mostly differentiate to OLs while SVZ-NSCs differentiate to neurons. In accordance, ME-NSCs preferentially differentiate to MBP^+^ OLs after transplantation to the LV of *Shi* mice, compared with SVZ-NSCs that differentiate toward neurons. Our results show that TSP1 favors neuronal differentiation of ME-NSCs, while an antagonist of TSP1 (LSKL) preferentially directs toward OLs. Finally, analysis of TSP1 in EAE mice shows decreased expression in the ME (versus SVZ) compared with naive mice.

These findings suggest the ME as an exclusive oligodendrogenic niche, an endogenous pool of OPCs, to enhance generation of OPCs under pathological conditions. Indeed, this study suggests that TSP1 plays as negative regulator of oligodendrogenesis *in vitro*.

Results {#sec2}
=======

Characterization of OPCs in the ME of the Hypothalamus {#sec2.1}
------------------------------------------------------

Brains of 8-week-old naive mice were analyzed for regions enriched with newly generated NSCs. C57Bl/6J mice were injected daily with BrdU for 3 days and brains were scanned for BrdU-enriched regions ([Figure 1](#fig1){ref-type="fig"}A). Comparative analysis revealed that the cortex (Ctx) and the striatum contain a minor population of BrdU^+^ cells compared with the CC, DG, and SVZ. Interestingly, another BrdU^+^-enriched region was identified in the ME ([Figure 1](#fig1){ref-type="fig"}B). To characterize the identity of BrdU^+^ cells in this region, brain sections of naive mice were stained for neuronal and oligodendrocyte progenitor markers. No staining was detected for the early neuronal progenitor marker (DCX) in the ME ([Figure 1](#fig1){ref-type="fig"}C), or for NeuN (not shown). Surprisingly, the ME contained a large number and high density of OPCs (NG2^+^ BrdU^+^) compared with the CC, DG, and SVZ ([Figure 1](#fig1){ref-type="fig"}D). The majority of these NG2^+^ cells were also PDGFRa^+^ ([Figures 1](#fig1){ref-type="fig"}E and [S1](#mmc1){ref-type="supplementary-material"}). Quantitation of NG2^+^ BrdU^+^/mm^2^ and their percentages indicated that the number and density of OPCs is markedly higher in the ME (608 ± 106 cells in ME compared with 400 ± 149 cells in DG, 290 ± 9.1 cells in SVZ and 73 ± 73 cells in CC; [Figures 1](#fig1){ref-type="fig"}F and 1G), suggesting that the ME of naive mice is rich with newly formed OPCs.Figure 1OPCs in the ME of Naive Mice(A) Scheme shows regions analyzed for BrdU^+^ cells.(B) BrdU staining in the ME DG, SVZ, CC, Ctx, and St.(C) Absence of neuronal progenitors (DCX) in the ME and CC compared with DG. Arrows indicate DCX^+^ BrdU^+^ cells.(D) Images show OPCs (NG2) in the DG, CC, SVZ, and ME boxed in (A). Arrows indicate NG2^+^ BrdU^+^ cells.(E) Images show NG2^+^ PDGFRa^+^ OPCs.(F and G) Quantitative analysis of NG2^+^ BrdU^+^ cells in the DG, CC, SVZ, and ME as (F) mean number of NG2^+^ BrdU^+^ cells/mm^2^. ^∗^p = 0.013, ^∗∗^p = 0.00079, and (G) as their mean percentage of BrdU^+^. ^∗^p = 0.0007 (n = 4 for each group).Scale bar, 50 μm.

Cells Originated from the ME Generate NS and Differentiate to Neuronal/Oligo Progenitor Cells {#sec2.2}
---------------------------------------------------------------------------------------------

ME cells were examined for self-renewal and assessed for their capability to generate NS compared with those from the SVZ ([Figure 2](#fig2){ref-type="fig"}A, schematic explanation). Interestingly, ME cells generated NS 3--4 weeks after plating, while SVZ-NS could be detected already 7 days after plating. Clearly, the ME-NS ([Figure 2](#fig2){ref-type="fig"}B), which contain many NG2^+^ OPCs and few DCX^+^ neuronal progenitors and GFAP^+^ astrocytes, showed pronounced differentiation to oligodendrocyte lineage ([Figure 2](#fig2){ref-type="fig"}C) compared with SVZ-NS ([Figures 2](#fig2){ref-type="fig"}D and 2E). Quantitative analysis indicated that ME-NS express DCX 2 days after differentiation (4.2 ± 0.6% of DAPI^+^ cells in ME-NS compared with 5.32 ± 1.1% in SVZ-NS), but that this neurogenic potential gradually decreases at days 4, 8, and 12 after differentiation and that markers of mature neurons (β-tubulin III and NF200) are poorly expressed as compared with SVZ-NS ([Figure 2](#fig2){ref-type="fig"}F). Analysis of cells that were differentiated to OPCs or mature OLs ([Figure 2](#fig2){ref-type="fig"}G) indicated that ME-NS preferentially differentiated to NG2^+^ OPCs 2 days after differentiation (2.67 ± 0.65% compared with 1.58 ± 1.84% in SVZ-NS) and their number gradually increased at days 4, 8, and 12 after differentiation (6.8 ± 1.4%, 7.9 ± 0.7%, and 18.5 ± 6%, respectively) compared with differentiation from SVZ-NS (5.1 ± 2.8%, 4.82 ± 1.8%, and 8.64 ± 3.6%, respectively). Moreover, the number of MBP^+^ mature OLs increased after 4, 8, and 12 days (13.4 ± 2.5%, 17.4 ± 4.2%, and 29.8 ± 3.4%, respectively) compared with differentiation from SVZ-NS (10.9 ± 0.85%, 16.1 ± 1.9%, and 15.2 ± 3.3%, respectively; [Figure 2](#fig2){ref-type="fig"}G). These results are confirmed by western blot (WB) of β-tubulin and MBP ([Figure S2](#mmc1){ref-type="supplementary-material"}).Figure 2ME Cells Generate NS and Differentiate *In Vitro* to Neuro/Oligo Progenitors(A) Explanation of NS culture and fixation schedule.(B and D) Generation of NS from (B) isolated ME compared with (D) SVZ cells. Expended ME-NS express markers of neuronal (DCX), oligodendrocyte progenitors (NG2), and astrocytes (GFAP). Shown are bright field images of NS and immunostaining for neural markers.(C and E) Temporal analysis of neural markers expressed by ME-NS (C) upon differentiation compared with (E) SVZ-NS and their quantitative analysis of (F) neuronal and (G) oligodendrocyte markers (G).Scale bar, 50 μm.

These results demonstrate the self-renewal capacity of ME cells and suggest that ME cells preferentially differentiate to OLs.

Increased Number of OPCs in the ME of EAE Mice {#sec2.3}
----------------------------------------------

The self-renewal capacity of ME cells and their potential to generate OLs prompted us to study the effect of a pathological condition, such as EAE, on newly generated OLs in the ME. Immunostaining for BrdU^+^ cells in the ME, CC, and DG clearly showed that EAE induced cell proliferation in these regions and especially in the ME compared with these regions from naive mice, and that a fraction of these BrdU^+^ cells was also NG2^+^ ([Figure 3](#fig3){ref-type="fig"}A, left panel), which was increased in EAE mice as compared with naive mice. In contrast, there was no evidence of DCX^+^ cells in the ME and CC compared with DG, although there was an increased number of BrdU^+^ cells ([Figure 3](#fig3){ref-type="fig"}A, right panel). Higher-magnification images of BrdU^+^ cells in the ME clearly showed that, under EAE, an increased cell proliferation was detected compared with the same region in naive mice ([Figure 3](#fig3){ref-type="fig"}B). The mean number of BrdU^+^ cells per ME was increased (by 2.7-fold; p \< 0.01) in EAE mice compared with naive mice ([Figure 3](#fig3){ref-type="fig"}C). Staining for macrophages and OPCs ([Figure 3](#fig3){ref-type="fig"}D) excluded the possibility that these parenchymal resident BrdU^+^ cells were immune cells that penetrated the CNS as the MAC2^+^ cells resided at the edge of ME tissue but not in the parenchyma where the BrdU^+^ cells were detected ([Figure 3](#fig3){ref-type="fig"}D). Moreover, the immune cell marker, CD45 staining, excluded the possibility that the NG2^+^ BrdU^+^ cells were infiltrating immune cells ([Figure 3](#fig3){ref-type="fig"}E). To characterize these newly generated cells, adjacent sections were immunostained for markers of OLs. Comparison of sections from EAE mice to sections of naive mice showed that BrdU^+^ cells expressed NG2 ([Figure 3](#fig3){ref-type="fig"}F, upper panel) or RIP of pre-myelinating OLs ([Figure 3](#fig3){ref-type="fig"}F, middle panel) and that their number was increased in EAE mice, while a comparable intensity of MBP immunoreactivity in the ME of naive and EAE mice was observed ([Figure S4](#mmc1){ref-type="supplementary-material"}A).Figure 3Increased Number of OPCs in the ME of EAE Mice(A) Images show NG2/BrdU and DCX/BrdU staining in the DG, CC, and ME.(B) Enhanced BrdU staining of ME in EAE mice compared with naive mice. Arrows indicate double-positive cells.(C) Increased BrdU^+^ cells in EAE mice compared with naive mice (n = 5 per group).(D) Macrophages (MAC2^+^) are not localized where OPCs are scored.(E) NG2^+^ cells are distinctive from CD45^+^ cells.(F and G) (F) Images of BrdU^+^ NG2^+^, BrdU^+^ RIP^+^ (arrowheads), and BrdU^+^ NG2^+^ RIP^+^ cells (arrows) in the ME of EAE mice and (G) their quantitative analysis (n = 4 per group).(H) Immunostaining for DCX or β-tubulin with BrdU in the ME.Scale bar, 50 μm. (C) ^∗^p \< 0.01, (G) ^∗^p = 0.02.

Moreover, numerous BrdU^+^ cells expressed both NG2 and RIP in sections from EAE mice compared with those from naive mice ([Figure 3](#fig3){ref-type="fig"}F, lower panel). The percentage of NG2^+^ BrdU^+^ and RIP^+^ BrdU^+^ cells increased in the ME of EAE mice by 13% and 8.4%, respectively. Moreover, a marked increase in the percentage of NG2^+^ RIP^+^ BrdU^+^ in EAE mice could be observed ([Figure 3](#fig3){ref-type="fig"}F). Of note, ME sections from EAE or naive mice showed neither BrdU^+^ co-expressing β-tubulin III nor DCX compared with such positive staining in the Ctx ([Figure 3](#fig3){ref-type="fig"}H). A small number of GFAP^+^ BrdU^+^ cells could be detected in the ME of EAE mice ([Figure 3](#fig3){ref-type="fig"}H). Notably, such oligodendrogenesis can be observed in the ventro-medial region (VMH) and the arcuate nucleus (Arc) of the hypothalamus, but to a lesser extent, and obviously the number of NG2^+^ BrdU^+^ cells is significantly higher in the ME of naive and EAE mice compared with the Arc and VMH ([Figure S3](#mmc1){ref-type="supplementary-material"}).

These results suggest that EAE extensively promotes oligodendrogenesis in the ME.

Expression of TSP1 by NSCs *In Vitro* and Spatial Analysis of TSP1 {#sec2.4}
------------------------------------------------------------------

TSP1 was implicated in the direction of SVZ-NSCs toward neuronal differentiation ([@bib37]), raising the possibility that TSP1 may act as negative regulator of oligodendrogenesis in ME. Hence, we compared the expression of TSP1 by SVZ-NSCs with that of ME-NSCs. Expression of TSP1 could not be detected in NS of ME or SVZ (data not shown). However, as shown in representative images ([Figure 4](#fig4){ref-type="fig"}A) and by quantitative analysis ([Figure 4](#fig4){ref-type="fig"}B), its expression in the ME was upregulated 2 and 4 days after differentiation and then significantly declined after 8 days. In contrast, expression of TSP1 in SVZ-NSCs was only slightly increased at days 2 and 4 after differentiation but increased after 8 days. In brain sections, TSP1 expression was decreased in ME of EAE mice compared with naive mice. However, TSP1 level in the SVZ was increased ([Figure 4](#fig4){ref-type="fig"}C), and the mean fluorescent intensity (MFI) confirmed these differences in TSP1 expression ([Figure 4](#fig4){ref-type="fig"}D). The MFI showed 1.5-fold increase in the SVZ of EAE mice compared with naive mice (p = 0.003), while there was 1.8-fold decrease in the ME of EAE mice compared with naive mice (p \< 0.001; [Figure 4](#fig4){ref-type="fig"}D). *Tsp1* relative expression in EAE mice was decreased by 2-fold in ME (p = 0.04; [Figure 4](#fig4){ref-type="fig"}E) compared with naive mice. Moreover, GFAP^+^ immunostaining indicated decreased TSP1 expression (control staining; [Figure S4](#mmc1){ref-type="supplementary-material"}B) by astrocytes in ME of EAE mice compared with naive mice and increase in the LV of EAE mice ([Figures 4](#fig4){ref-type="fig"}F and [S4](#mmc1){ref-type="supplementary-material"}C, low power images).Figure 4Expression of TSP1 by ME- and SVZ-NSCs(A and B) (A) Immunostaining for GFAP and TSP1 after the indicated time points of differentiation and (B) quantitative analysis of TSP1 fluorescence intensity (n = 6).(C) Images of immunostaining for TSP1 in SVZ and ME.(D) Quantitative analysis of TSP1 fluorescence intensity in SVZ and ME (n = 4 per group). ^∗^p = 0.003, ^∗∗^p = p \< 0.001.(E) *Tsp1* relative expression in the ME and SVZ. ^∗^p = 0.036.(F) Orthogonal views of GFAP and TSP1 in ME and SVZ in naive mice compared with EAE mice. Low-power images of TSP1 are shown in [Figure S4](#mmc1){ref-type="supplementary-material"}C. Scale bar, 50 μm.

Effect of TSP1 on Differentiation of NSCs from SVZ versus ME and Expression of TSP1 by NSCs {#sec2.5}
-------------------------------------------------------------------------------------------

The increased number of OPCs in the ME of EAE mice and the decreased TSP1 expression hints on the role of TSP1 as negative regulator of oligodendrogenesis. To study this possibility, SVZ- or ME-NSCs were differentiated for 8 days in the absence or presence of TSP1 or bovine serum albumin (BSA) as a control (both at 2 μg/mL) and cultures were stained against NG2 and DCX ([Figure 5](#fig5){ref-type="fig"}A, schematic explanation). Incubation with TSP1 resulted in significantly reduced number of NG2^+^ OPCs differentiated from both SVZ- and ME-NSCs, especially in ME-NSCs compared with BSA or vehicle control ([Figure 5](#fig5){ref-type="fig"}B). Inversely, addition of TSP1 increased the number of neuronal progenitors in ME-NSCs and dramatically in SVZ-NSCs. Quantitative analysis showed that incubation with TSP1 increased the number of DCX^+^ neuronal progenitors differentiated from SVZ-NSCs by 12% and decreased NG2^+^ OPCs by almost 4% ([Figure 5](#fig5){ref-type="fig"}C).Figure 5Effect of TSP1 on Differentiation of ME-NSCs Compared with SVZ-NSCs(A) Explanation of NS culture, differentiation in presence of TSP1, and fixation schedule.(B) Staining for DCX and NG2 in ME- and SVZ-NSCs cultures treated with TSP1 or BSA. NSCs cultured in differentiation medium served as control. Shown are representative images out of three repeats.(C and D) Quantitative analysis of (C) SVZ-NSC and (D) ME-NSC differentiation to DCX^+^ cells and NG2^+^ cells in the presence of TSP1 (mean ± SD). Scale bar, 50 μm. ^∗^p ≤ 0.004, ^∗∗^p ≤ 0.005.

A similar effect could be detected in differentiation of ME-NSCs, where TSP1 increased the number of neuronal progenitors by 8.2% and dramatically decreased the number of OPCs (by ∼13%) relative to control cultures ([Figure 5](#fig5){ref-type="fig"}D). A WB for the neuronal β-tubulin and oligodendroglial GST-pI confirmed these results ([Figure S5](#mmc1){ref-type="supplementary-material"}).

TSP1 Antagonist Shifts NSC Differentiation toward OPCs {#sec2.6}
------------------------------------------------------

To further confirm a role for TSP1 as a negative regulator of oligodendrogenesis *in vitro*, we studied the differentiation of ME-NSCs compared with SVZ-NSCs in the presence of TSP1 antagonist LSKL, a 4-amino acid peptide that specifically blocks the binding of TSP1 and the large latent transforming growth factor β (TGF-β) complex ([@bib33]). ME- or SVZ-NSCs were differentiated in the presence of LSKL or its control-scrambled peptide SLLK (50 μg/mL) and labeled for NG2 and DCX ([Figure 6](#fig6){ref-type="fig"}A, schematic explanation). Incubation with TSP1 antagonist increased the number of OPCs differentiated from both SVZ- and ME-NS, especially in SVZ-NSCs. Inversely, the TSP1 antagonist reduced the number of neuronal progenitors in ME- and SVZ-NSCs ([Figure 6](#fig6){ref-type="fig"}B). Quantitative analysis showed that incubation with the TSP1 antagonist significantly increased the number of NG2^+^ OPCs differentiated from SVZ-NSCs by 7%, and decreased the number of DCX^+^ neuronal progenitors by almost 4% ([Figure 6](#fig6){ref-type="fig"}C). Similarly, the TSP1 antagonist increased the number of NG2^+^ OPCs differentiated from ME-NSCs by almost 3%, and decreased the number of DCX^+^ neuronal progenitors by 2.4%, compared with control cultures ([Figure 6](#fig6){ref-type="fig"}D). A WB for the neuronal β-tubulin and oligodendroglial GST-pI confirmed these results ([Figure S6](#mmc1){ref-type="supplementary-material"}). Altogether, these results further suggest that TSP1 negatively regulates oligodendrogenesis *in vitro*.Figure 6Effect of TSP1 Antagonist on Differentiation of ME-NSCs Compared with SVZ-NSCs(A) Explanation of NS culture, differentiation in the presence of TSP1 antagonist or control peptide and fixation schedule.(B) Staining for DCX and NG2 in ME- and SVZ-NSCs cultures treated with TSP1 antagonist (LSKL) or control peptide (SLLK) (50 μg/mL).(C and D) Quantitative analysis of (C) SVZ-NSCs and (D) ME-NSCs differentiation to DCX^+^ and NG2^+^ cells in the presence of TSP1 antagonist (mean ± SD). Scale bar, 50 μm. ^∗^p ≤ 0.004, ^∗∗^p ≤ 0.015.

ME-Originated Cells Preferentially Generate MBP^+^ OLs in the CNS of *Shi* Mice {#sec2.7}
-------------------------------------------------------------------------------

The *in vitro* results show that ME-NS can differentiate to mature MBP^+^ OLs ([Figure 2](#fig2){ref-type="fig"}), express chemokine receptor for migration, and provide neurotrophic support ([Figures S7](#mmc1){ref-type="supplementary-material"}A and S7B). To unambiguously determine whether grafted ME-NSCs become fully mature myelinating OLs, ME-NSCs derived from GFP mice were grafted into the LV of *Shi* mice lacking MBP ([@bib60]). Hence, MBP labeling in their brain can only come from grafted cells.

Two-week-old *Shi* mice were transplanted with either ME- or SVZ-NS (n = 4 per group). At 3 weeks post-grafting, GFP^+^ cells derived from ME-NS had migrated and were found mainly in the CC and rarely in LV, while GFP^+^ cells derived from SVZ-NS were detected mainly in the LV and in the parenchyma in the vicinity of the LV ([Figure 7](#fig7){ref-type="fig"}A). These results confirm the ability of adult SVZ- and ME-NS to survive in the LV and CC of *Shi* mice, respectively, after migration and differentiation. Higher-magnification images showed GFP^+^ cells derived from ME-NS in the CC that co-express MBP. Such GFP^+^ MBP^+^ cells could be observed also in the parenchyma at the vicinity of LV but to a lower extent. The pattern of MBP labeling indicated that grafted cells had formed myelin patches throughout the CC ([Figures 7](#fig7){ref-type="fig"}B, upper set of panels and [S7](#mmc1){ref-type="supplementary-material"}C) with process-bearing ramified GFP^+^ cells that co-express MBP ([Figure 7](#fig7){ref-type="fig"}B, inset in upper right set of panels). As shown in [Figure 7](#fig7){ref-type="fig"}B (middle set), only a small number of GFP^+^ cells derived from ME-NS also expressed DCX in the CC. In addition, although these GFP^+^ cells were detected at the vicinity of LV, none co-expressed DCX. Analysis the fate of SVZ-NS showed that only few GFP^+^ cells derived from SVZ-NS co-expressed MBP in the CC ([Figure 7](#fig7){ref-type="fig"}C, upper left set of panels), a typical niche of OLs, while no MBP^+^ GFP^+^ cells could be detected in the LV ([Figure 7](#fig7){ref-type="fig"}C, lower left set of panels). However, while only few GFP^+^ cells derived from SVZ-NS co-expressed the neuronal marker DCX in CC ([Figure 7](#fig7){ref-type="fig"}C lower right set of panels), the frequency of such cells was higher in the parenchyma near the LV with a morphology reminiscent of neurons ([Figure 7](#fig7){ref-type="fig"}C, inset in upper right set of panels).Figure 7ME-Derived OLs Express MBP in *Shi* MiceCoronal brain sections processed 3 weeks after injection of GFP-labeled NS into the LV.(A) Images show GFP^+^ ME-NS (upper panel) or GFP^+^ SVZ-NS.(B) Images show transplanted GFP^+^ ME-NSCs in the ME (upper panel) and SVZ (lower panel) expressing MBP (left column) or DCX (middle column). Upper images in the right column show higher magnification of GFP^+^ MBP^+^ in the CC. Scale bars, 20 μm and 10 μm (inset). The lower image is an orthogonal view showing localization of MBP with GFP^+^ ME-NSCs. Scale bar, 10 μm.(C) Images show GFP^+^ SVZ-NSCs in the CC (upper panel) and adjacent LV (lower panel). Shown are immunostaining for MBP (left column) and DCX (middle column). Upper images in the right column show higher magnification of GFP^+^ DCX^+^ in the SVZ. Scale bars, 20 μm and 10 μm (inset). The lower image is orthogonal view showing localization of DCX with GFP^+^ SVZ-NSCs. Scale bar, 10 μm.(D) Quantitative analysis of GFP^+^ cells co-express MBP or DCX in *Shi* mice transplanted with ME-NSCs compared with SVZ-NSCs (n = 5 per group). Scale bars, 50 μm (A--C). ^∗^p \< 0.001.

Quantification 3 weeks after transplantation showed that 32.9 ± 8.8% of GFP^+^ cells derived from ME-NS co-expressed MBP. Most of them were detected in the myelinogenic area, such as the CC, while only 0.8% co-expressed the neuronal marker DCX and were detected near the LV ([Figure 7](#fig7){ref-type="fig"}D). Inversely, only 3.1 ± 6% of GFP^+^ cells derived from SVZ-NS co-expressed MBP^+^, while 29 ± 9% of these cells co-expressed DCX and were mostly detected in the vicinity of the LV ([Figure 7](#fig7){ref-type="fig"}D). These results suggest that ME-NS preferentially generate OLs in adult subcortical white matter after a heterotopic graft compared with SVZ-NS and that oligodendrogenic or neurogenic fate chosen by NS depended not only on the environment cues encountered in the host regions but also on intrinsic features of the cells origin.

Discussion {#sec3}
==========

Here, we show that the ME of naive mice is enriched with BrdU^+^ cells identified as NG2^+^ cells and that the number of these BrdU^+^ NG2^+^ cells is increased in the ME of EAE mice. Interestingly, these cells can generate NS *in vitro.* In line with the *in situ* observation, ME-NSCs mostly differentiate to OLs upon *in vitro* differentiation. In accordance, these ME-NSCs preferentially differentiate to MBP^+^-producing OLs after transplantation to the LV of *Shi* mice. Mechanistically, our results show that TSP1 favors neuronal differentiation of ME-NSCs, while the TSP1 antagonist preferentially directs differentiation to OLs. Finally, analysis of TSP1 expression in EAE mice shows decreased expression in the ME (versus SVZ) compared with naive mice, which is in accordance with the effect of TSP1 *in vitro*.

These findings suggest that the ME is an exclusive oligodendrogenic niche that can serve as an endogenous pool of OPCs, and as a target to enhance the generation of OPCs under pathological conditions. Indeed, this study suggests that TSP1 plays a negative regulator of oligodendrogenesis *in vitro*.

Our study shows that the ME, considered as a CVO ([@bib23]), is enriched with BrdU^+^ cells both in naive and to a greater extent in EAE mice, can generate NS and differentiate to neurons and OLs, as described previously ([@bib6], [@bib36], [@bib48], [@bib49]). Interestingly, ME-NSCs preferentially differentiate to OLs, corroborated by the *in vivo* results showing that BrdU^+^ cells in the ME are NG2^+^, while no immunoreactivity for neuronal marker with BrdU^+^ can be detected. BrdU^+^ NG2^+^ cells in the ME may represent a pool of latent progenitors, which are relatively quiescent in the brain of naive mice, yet possess the potential to proliferate and differentiate under specific circumstances. In this regard, like other CVOs, with their abundance of fenestrated capillaries and their proximity to ventricles, the ME may be ideally positioned to response to pathological conditions such as inflammation, stroke ([@bib36]), traumatic brain injury ([@bib21]), or physiological cues, suggesting that signaling factors present in blood may be relevant to stimulating the ME niche to generate OPCs. In support of this notion, [@bib31] showed that ciliary neurotrophic factor robustly induces cell proliferation in the hypothalamus.

An interesting issue is the physiological significance of the increased OPCs in the ME, which was mainly studied with respect to energy balance, weight loss, and nutritional signaling ([@bib18], [@bib30]), but not with demyelinating conditions.

In the pathological context, our findings of increased number of OPCs in the ME of EAE mice, and particularly their differentiation to pre-myelinating OLs and MBP^+^ cells, suggest these OPCs as a backup pool to replace mature OLs that turnover with time, for OLs that support sensory neurons and essential for balance of body energy and metabolism rather than represent a transient population with myelin-unrelated roles.

Hence, our study suggesting the role of these OPCs during myelin repair further shed light on the pathological context of OPCs pool in the ME.

As a CVO, the ME is exposed to many factors that may maintain stem cells under normal physiological conditions and, like known neurogenic SVZ and SGZ regions, the ME microenvironment may possess factors critical for maintaining progenitors and regulating differentiation ([@bib21]). Similarly, numerous studies show that dehydration stress ([@bib59]) or demyelination ([@bib42]) promote proliferation of OPCs. In line with our findings, recent studies demonstrated enhanced proliferation in the ME in a stroke model, however, and interestingly the proportion of differentiating neurons was significantly increased after focal ischemic stroke (MCAO) compared with OLs and astrocytes, representing a shift toward neurogenesis in the injured brain ([@bib21], [@bib36]). This raises the possibility of niche plasticity and differentiation on demand upon injury. Intriguingly, we could not detect neuronal progenitors in the ME as shown previously ([@bib36], [@bib48], [@bib49]). These differences could be attributed to methodological disparities between studies.

Our data suggest that the ME predominantly give rise to OPCs and OLs in healthy brain, which is enhanced in demyelinating condition. Such remyelination capacity of SVZ-NSCs was demonstrated in an EAE model ([@bib43]) and of OPCs from human fetal forebrain transplanted in *Shi* mice ([@bib61]).

Although we did not track the origin of OPCs lining the ME, recent findings evidently suggest that stem cells in this region do not migrate there from other areas of high stem cell proliferation (i.e., SVZ) and instead the third and fourth ventricles are likely novel niches for stem cell production ([@bib36]).

Beside the SVZ and SGZ, neurogenesis may occur in other areas of the adult brain; CA1 ([@bib46]), neocortex ([@bib25], [@bib26]), striatum ([@bib5]), amygdala ([@bib7]), substantia nigra ([@bib65]), third ventricle ([@bib64]), subcortical white matter ([@bib38]), caudate nucleus ([@bib53]), and leptomeninges ([@bib8]). However, regions of oligodendrogenesis except for Ctx were purely characterized ([@bib41], [@bib62]). [@bib59] showed that the adult neurohypophysis contains glial progenitors capable of differentiating into OLs but the structure does not harbor NSCs. [@bib42] showed that EAE associated with demyelination enhances proliferation in SVZ and promotes mobilization of SVZ cells to demyelinated white matter structures, generating neurons and OLs. [@bib50] reported that cells isolated from the SCZ and cultured as NS behave as NSCs *in vitro* and migrate into the CC to become OLs *in vivo*.

These studies support our data showing the oligodendrogenic fate of newly generated cells in the ME of naive mice. Moreover, this oligodendrogenesis is enhanced in EAE mice. Our finding that these newly generated cells in the ME can be detected in naive mice (also shown by [@bib49]) and express the RIP marker of pre-myelinating OLs suggests that these cells do not migrate from other neurogenic regions but represent ME-resident cells with proliferation capacity. It is intriguing if the ME is exclusively oligodendrogenic as shown here, although a low percentage of neuronal progenitors differentiated from ME-NS could be detected *in vitro*, which may result from the lack of the *in vivo* environmental cues characterizing the ME. In accordance with this notion, [@bib32] shows that fewer than 1% of proliferating cells in the SVZ are NG2 cells which are more abundant in the nonneurogenic parenchyma, suggesting that NG2^+^ OPCs are distinct from cellular constituents of the SVZ known as type A, B, or C cells ([@bib3]) and that the SVZ is mostly neuronogenic. Consistently, our study strongly suggests that the ME is an oligodendrogenic rather than an neuronogenic niche, corroborated by the absence of BrdU^+^ cells co-expressing markers of neuronal progenitors in the ME.

As with neurogenesis ([@bib36]), the production of OLs is restricted ([@bib39]), demonstrated to arise from the tissue microenvironment, which led to the emerging concept of an "oligodendrogenic niche." However, the possibility that neuro/oligodendrogenesis is directed by combination of both extrinsic and intrinsic factors should be considered as well. The adult neural parenchyma contains a widely distributed potential for oligodendrogenesis that is not expressed in standard conditions, but which may be recruited for brain repair ([@bib11]). It could be speculated that niche-dependent differences are mediated by adaptations of OPCs to their environment by reacting to local signaling ([@bib58]).

Astrocytes induce formation of excitatory synapses by secreting TSP1/2 ([@bib16]). Our results showing that SVZ-residing astrocytes of EAE mice express high level of TSP1 are consistent with the evidence that reactive astrocytes showing increased expression of TSP1, suggesting that these astrocytes are likely A2 type.

TSP1 was proposed to play a role in neuronal differentiation but inhibit differentiation of SVZ-NS toward OLs ([@bib37]). Consistently, our *in vitro* and *in vivo* data suggest that astrocytic TSP1 plays a negative regulator of the oligodendrogenic fate of ME-NSCs both as an intrinsic and an extrinsic factor. Notably, TSP1 staining in the brain appears widely and diffusely, suggesting that there might be another source than just the astrocytes, likely neurons ([@bib57]) and activated microglia ([@bib47]), which are highly abundant under neuroinflammation. In this study, LSKL, which blocks the binding of TSP1 and the large latent TGF-β complex, antagonized the effect of TSP1, suggesting that the effect of TSP1 is mediated by TGF-β. This notion is further sustained by the decreased expression of TSP1 in the ME of EAE mice associated with increased number of OPCs.

While the SVZ-NSCs mostly generate neuronal lineage and only a few OLs with some lineage plasticity in pathological conditions ([@bib4]), our study demonstrates the oligodendrogenic potential of the ME both *in vitro* and *in vivo* and the role of TSP1 as a negative regulator of oligodendrogenesis *in vitro*. Our findings suggest the ME niche as a pool of "backup" OPCs that can differentiate in the case of injury to surrounding OLs and as a target for enhancement of oligodendrogenesis while devising therapies for demyelination diseases.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

C57Bl/6J and SJL/J mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA) or obtained from the Weizmann Institute colony. (C57Bl/6J x SLJ/J)F1 mice were bred at the Weizmann Institute Animal Facility. *Shi* mice were purchased from Jackson Laboratory. All animals were handled according to the regulations formulated by the Institutional Animal Care and Use committee of the Weizmann Institute (permit no. 02820711-3) and were performed in compliance with its relevant guidelines and regulations.

Reagents and Antibodies {#sec4.2}
-----------------------

The mouse PLP139-151 peptide was synthesized in the laboratory of Prof. M. Fridkin (Department of Organic Chemistry, The Weizmann Institute of Science), using the Fmoc technique with an automated peptide synthesizer (AMS422; Abimed, Langenfeld, Germany). For list of antibodies see [Table S1](#mmc1){ref-type="supplementary-material"}.

Active Induction of EAE {#sec4.3}
-----------------------

(C57Bl/6J × SJL/J)F~1~ mice (6- to 8-week-old female) were immunized, observed, and scored as described previously ([@bib66]).

Administration of BrdU and Tissue Processing {#sec4.4}
--------------------------------------------

When reached a maximal clinical score (3) usually at day 20 post-immunization, mice were injected i.p. with BrdU (Sigma-Aldrich; 50 mg kg^−1^ body weight) daily for 3 days and then were sacrificed. Animals were deeply anesthetized with a xylazine/ketamine mixture and perfused intracardially with cold 4% paraformaldehyde (PFA). Brains were postfixed in 2% PFA and cryoprotected in a 15% sucrose solution. Free-floating sections (30 μm thick) were cut coronally with a sliding microtome (Leica SM, 2000r; Leica, Nussloch, Germany).

NSCs Culture from SVZ and ME {#sec4.5}
----------------------------

NSCs were generated from the SVZ of the LV or the ME of the hypothalamus from brains of C57Bl/6J mice (6--8 weeks old) as described ([@bib66]). For fate tracking, ME- and SVZ-NSCs were generated from GFP mice (kindly provided by the lab of Michal Schwartz, Department of Neurobiology, The Weizmann Institute of Science). NS were differentiated by plating on poly-D-lysine (PDL) (Sigma-Aldrich, Rehovot, Israel), in growth factor-free NS medium containing 3% serum (differentiation medium). For immunocytochemistry, cells were plated on PDL-coated coverslips. To study the effect of TSP1, NS were differentiated in the presence of 2 μg/mL TSP1 (kindly provided by the lab of Prof. Jonathan Kipnis, University of Virginia, Charlottesville, VA, USA) or BSA, and replaced everyday with fresh TSP1 and BSA for 8 days. To study the effect of TSP1 antagonist LSKL and its control-scrambled peptide SLLK, NS were differentiated in the presence of 50 μg/mL of either of the peptides (GenScript) and replaced every alternate day for 8 days.

qRT-PCR Analysis {#sec4.6}
----------------

cDNA (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}) was subjected for qRT-PCR in triplicates using the 7500 Real-Time PCR system (Applied Biosystems, Foster City, CA, USA), and TaqMan Universal PCR Master Mix (Applied Biosystems) with TaqMan gene expression assays of mouse target genes. Relative expression was calculated by Relative Quantification software (Roche Diagnostics) using β-actin for normalization.

Primers sequences used for amplification were as follows:

TSP1: TaqMan Real-Time ready assay ID: Mm00449020_g1

β-Actin: TaqMan Real-Time ready assay ID: Mm00607939_s1

Immuno Labeling {#sec4.7}
---------------

### Immunocytochemistry {#sec4.7.1}

Coverslips were washed with PBS, fixed with 2% PFA, and immune labeled as described previously ([@bib66]), except for the additional primary antibodies used, monoclonal anti-NeuN (1:400) and monoclonal anti-TSP1 (1:200). Nuclei were visualized by DAPI counterstaining. Slides were examined using an LSM 510 laser scanning confocal microscope (Carl Zeiss, Jena, Germany). Digital images were acquired using the Zeiss LSM 510 software (magnifications, ×40 or ×63).

### Immunoflourescent Staining of Tissue Sections {#sec4.7.2}

Free-floating sections of brain were washed twice in PBS followed by blocking in either 3% rabbit (for goat anti-DCX, mouse anti-RIP) or goat serum (for rabbit anti-NG2) depending on primary antibodies used and 0.1% Triton X-100 in PBS for 1 h at room temperature (RT). Sections were stained as described previously ([@bib66]), except for the additional primary antibodies used, mouse anti-TSP1 (1:200), rat anti-BrdU (1:200), mouse anti-RIP (1:100) rat anti-MAC2 (100), and rat anti-CD45 (1:100). For BrdU labeling, sections were primarily incubated with 2N HCl at 37°C for 30 min, and rinsed in 0.1 M (pH 8.5) borate buffer at RT for 10 min, rinsed twice in PBS, blocked and immune labeled. Images were acquired as described above. Confocal Z-stacks were taken, and cell numbers were counted manually.

### Quantification {#sec4.7.3}

Immunofluorescence data that were collected from three independent repeats of experiment (n = 6 from each) provided an independent sampling. Analysis of qPCR was from three independent repeats. For morphometric analysis, we used repeats from at least three independent experiments with data obtained from six images (of randomly chosen field of view under ×20 objective) for each time point per condition. Statistical significance was assessed by unpaired two-tailed Student\'s t test (Excel software). p values \< 0.05 were considered significant. All data are presented as mean ± standard error. ImageJ densitometry software (version 1.36, NIH, Bethesda, MD, USA) was used for quantification of TSP1 intensity.
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This paper is dedicated to the memory of A.B.-N., who recently passed away. Ben-Nun was a strong-minded, vigorous, and inspiring scientist in the field of immunology and autoimmunity research. He was a real friend, a very kind and gentle person.

Supplemental Information can be found online at <https://doi.org/10.1016/j.stemcr.2020.04.005>.
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